Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
06 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/04/3094067/0/en/HUTCHMED-and-Innovent-Jointly-Announce-NDA-Acceptance-in-China-for-Fruquintinib-Combination-with-Sintilimab-for-the-Treatment-of-Advanced-Renal-Cell-Carcinoma.html
04 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/innovents-ibi363-pd-1il-2-bias-bispecific-antibody-fusion-protein-receives-second-nmpa-breakthrough-therapy-designation-for--immuno-resistant-squamous-non-small-cell-lung-cancer-302473851.html
03 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/2025-asco-oral-presentation-innovent-biologics-announces-updated-data-of-ibi363-first-in-class-pd-1il-2-bias-bispecific-antibody-fusion-protein-from-the-phase-1-poc-clinical-study-in-advanced-non-small-cell-lung-cancer-302472525.html
01 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/2025-asco-oral-presentation-innovent-biologics-announces-updated-date-of-ibi363-first-in-class-pd-1il-2-bias-bispecific-antibody-fusion-protein-from-phase-1-clinical-studies-in-advanced-colorectal-cancer-302470217.html
31 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/asco-2025-oral-presentation-innovent-biologics-announces-updated-data-of-ibi363-first-in-class-pd-1il-2--bias-bispecific-antibody-fusion-protein-from-phase-1-and-2-clinical-studies-on-immunotherapy-treated-advanced-malignant--302470081.html
28 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/innovent-announces-a-phase-3-study-of-picankibart-anti-il-23p19-antibody-completes-first-participant-dosing-exploring-biologics-switching-treatment-for-psoriasis-patients-with-prior-inadequate-response-to-anti-il-17-antibodies-302467783.html
ABOUT THIS PAGE